Sofinnova Investments, Inc. Q4 2019 Filing
Filed February 14, 2020
Portfolio Value
$1.4T
Holdings
59
Report Date
Q4 2019
Filing Type
13F-HR
All Holdings (59 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ASNDAscendis Pharma A/S | 1,109,874 | $154.4B | 11.13% | |
| 2 | NXTCNextcure, Inc | 2,671,856 | $150.5B | 10.85% | |
| 3 | KRTXKaruna Therapeutics, Inc. | 1,885,602 | $142.1B | 10.24% | |
| 4 | AMRNAmarin | 5,208,305 | $111.7B | 8.05% | |
| 5 | NTRANatera | 3,100,560 | $104.5B | 7.53% | |
| 6 | —Principia Biopharma | 1,417,258 | $77.6B | 5.60% | |
| 7 | YMABUSDY-mAbs Therapeutics, Inc | 2,194,278 | $68.6B | 4.94% | |
| 8 | GRTXGalera Therapeutics, Inc | 3,083,712 | $40.6B | 2.93% | |
| 9 | BMRNBiomarin Pharmaceutical Inc | 441,872 | $37.4B | 2.69% | |
| 10 | CHRSCoherus BioSciences | 1,933,221 | $34.8B | 2.51% | |
| 11 | VRTXVertex Pharmaceuticals Inc | 139,164 | $30.5B | 2.20% | |
| 12 | MRUSMerus N.V. | 1,961,039 | $27.6B | 1.99% | |
| 13 | PTCTPTC Therapeutics Inc | 517,092 | $24.8B | 1.79% | |
| 14 | MRKMerck & Co Inc | 240,806 | $21.9B | 1.58% | |
| 15 | BIIBBiogen Inc | 63,711 | $18.9B | 1.36% | |
| 16 | REGNRegeneron Pharmaceuticals Inc | 50,086 | $18.8B | 1.36% | |
| 17 | —ObsEva SA | 4,749,623 | $18.1B | 1.31% | |
| 18 | UTHUnited Therapeutics Corp | 188,645 | $16.6B | 1.20% | |
| 19 | CCXIEURChemoCentryx Inc | 376,944 | $14.9B | 1.07% | |
| 20 | —Nucana Biomed Ltd | 2,400,000 | $14.6B | 1.06% | |
| 21 | —MyoKardia Inc | 195,871 | $14.3B | 1.03% | |
| 22 | MRTXEURMirati Therapeutics Inc | 108,383 | $14.0B | 1.01% | |
| 23 | —Nucana Biomed Ltd | 2,266,666 | $13.8B | 1.00% | |
| 24 | MGNXMacroGenics Inc | 1,173,882 | $12.8B | 0.92% | |
| 25 | FATEFate Therapeutics Inc | 635,143 | $12.4B | 0.90% | |
| 26 | ALNYAlnylam Pharmaceuticals Inc | 100,000 | $11.5B | 0.83% | Call |
| 27 | SRPTSarepta Therapeutics Inc | 87,818 | $11.3B | 0.82% | |
| 28 | —Kadmon Holdings Inc | 2,368,958 | $10.7B | 0.77% | |
| 29 | KNSAKiniksa Pharmaceuticals, Ltd | 922,700 | $10.2B | 0.74% | |
| 30 | —Medicines Co | 110,000 | $9.3B | 0.67% | Put |
| 31 | TGTXTG Therapeutics Inc | 811,292 | $9.0B | 0.65% | |
| 32 | —Calithera Biosciences Inc | 1,458,821 | $8.3B | 0.60% | |
| 33 | —Dermira Inc | 545,466 | $8.3B | 0.60% | |
| 34 | —Alexion Pharmaceuticals Inc | 75,000 | $8.1B | 0.58% | Call |
| 35 | —Chiasma | 1,630,221 | $8.1B | 0.58% | |
| 36 | XLRNAcceleron Pharma Inc | 147,032 | $7.8B | 0.56% | |
| 37 | ITRMIterum Therapeutics | 1,726,514 | $7.8B | 0.56% | |
| 38 | —ArQule Inc | 387,469 | $7.7B | 0.56% | |
| 39 | BCRXBioCryst Pharmaceuticals Inc | 2,151,164 | $7.4B | 0.53% | |
| 40 | —Entasis Therapeutics Holdings Inc. | 1,180,178 | $5.9B | 0.42% | |
| 41 | OTICEUROtonomy Inc | 1,515,629 | $5.8B | 0.42% | |
| 42 | SGENEURSeattle Genetics Inc | 50,000 | $5.7B | 0.41% | |
| 43 | —Forty Seven Inc | 138,643 | $5.5B | 0.39% | |
| 44 | —Zymeworks Inc | 107,552 | $4.9B | 0.35% | |
| 45 | AM6Amicus Therapeutics Inc | 475,330 | $4.6B | 0.33% | |
| 46 | XBITXBiotech Inc | 240,995 | $4.5B | 0.32% | |
| 47 | ORTXUSDOrchard Therapeutics PLC | 283,406 | $3.9B | 0.28% | |
| 48 | —Foamix Pharmaceuticals Ltd | 1,162,176 | $3.9B | 0.28% | |
| 49 | APLTApplied Therapeutics Inc | 134,825 | $3.7B | 0.27% | |
| 50 | ACRSAclaris Therapeutics | 1,911,573 | $3.6B | 0.26% | |
| 51 | —Dicerna Pharmaceuticals Inc | 159,512 | $3.5B | 0.25% | |
| 52 | KALAKala Pharmaceuticals Inc | 664,641 | $2.5B | 0.18% | |
| 53 | APLSApellis Pharmaceuticals, Inc | 49,580 | $1.5B | 0.11% | |
| 54 | —Synlogic Inc. | 574,972 | $1.5B | 0.11% | |
| 55 | FIXXEURHomology Medicines Inc | 64,397 | $1.3B | 0.10% | |
| 56 | HALOHalozyme Therapeutics Inc | 72,481 | $1.3B | 0.09% | |
| 57 | HRTXHeron Therapeutics Inc | 50,500 | $1.2B | 0.09% | |
| 58 | RYTMRhythm Pharmaceuticals Inc | 21,319 | $489.0M | 0.04% | |
| 59 | PDSBPDS Biotechnology Corporation | 142,635 | $378.0M | 0.03% |